Conventional wisdom has held that some types of cholesterol may help prevent heart disease, but government researchers have found evidence to the contrary. The findings could change the way doctors treat millions of heart patients.
It’s been a rough few months for eggs, following a massive salmonella-related recall. But there is a slight bit of decent news for the chicken ova industry: The eggs being popped into folks’ frying pans today aren’t as bad for your arteries as they were not so long ago.
British researchers are recommending that fast food joints pass out cholesterol-reducing statins to be consumed alongside cheeseburgers and the like in order to “neutralize” the heart risks of fatty foods.
Well, it seems that Pfizer is ready to move on from that embarrassing “Dr. Jarvik is not actually licensed to practice medicine” kerfuffle back in February. The company pulled its Lipitor spots after Congress became very interested in whether or not the ads were misleading the public into believing that Dr. Jarvik was qualified to offer medical advice — and that he was really rowing that boat. Now, theWall Street Journal has a tantalizing preview of the new “Dr. Jarvik Free” Lipitor ad. The spot features a regular person named John — a heart attack survivor who urges you to learn from his example and be more proactive about controlling your cholesterol (with Lipitor, damn it! Lipitor!).
A clinical trial of Zetia, a popularly prescribed cholesterol-lowering drug, “failed to show that the drug has any medical benefits.” In fact, fatty plaques grew almost twice as fast in patients who took Zetia along with Zocor in a combo product called Vytorin. However, “patients who are taking Vytorin or Zetia should talk to their doctors if they are concerned and not discontinue taking the medicines on their own.” [New York Times]
Target’s in-house brand, Archer Farms, is going trans-fat free this year, announced the company today. The private label has over 2,000 products and “will be the first national store brand to eliminate added trans fats from its entire product line.”
Pfizer is in panic mode about its rapid decline in Lipitor sales—in the last 18 months, it has dropped from 40% of the market for cholesterol-lowering drugs to 30%, and likely to drop further—so it’s launched a big media-blitz to convince people not to switch to simvastatin, the generic version of its name-brand competitor, Zocor. Zocor was more expensive than Lipitor, so Pfizer had nothing to worry about for years—but then Zocor lost its patent protection last year, and now doctors are switching patients from Lipitor over to Zocor’s generic twin to save money.
Hardee’s is marketing its new 930 calorie, 63 grams of fat Philly Cheesesteak Thickburger with the line “Now meat is a condiment.”